237 related articles for article (PubMed ID: 21098038)
1. Quantitative analysis of ERK2 interactions with substrate proteins: roles for kinase docking domains and activity in determining binding affinity.
Burkhard KA; Chen F; Shapiro P
J Biol Chem; 2011 Jan; 286(4):2477-85. PubMed ID: 21098038
[TBL] [Abstract][Full Text] [Related]
2. Spatially separate docking sites on ERK2 regulate distinct signaling events in vivo.
Dimitri CA; Dowdle W; MacKeigan JP; Blenis J; Murphy LO
Curr Biol; 2005 Jul; 15(14):1319-24. PubMed ID: 16051177
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel extracellular signal-regulated kinase docking domain inhibitors.
Hancock CN; Macias A; Lee EK; Yu SY; Mackerell AD; Shapiro P
J Med Chem; 2005 Jul; 48(14):4586-95. PubMed ID: 15999996
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and biological functions of the N-terminal, noncatalytic domain of extracellular signal-regulated kinase 2.
Eblen ST; Catling AD; Assanah MC; Weber MJ
Mol Cell Biol; 2001 Jan; 21(1):249-59. PubMed ID: 11113199
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity.
Roux PP; Richards SA; Blenis J
Mol Cell Biol; 2003 Jul; 23(14):4796-804. PubMed ID: 12832467
[TBL] [Abstract][Full Text] [Related]
6. Examining docking interactions on ERK2 with modular peptide substrates.
Lee S; Warthaka M; Yan C; Kaoud TS; Ren P; Dalby KN
Biochemistry; 2011 Nov; 50(44):9500-10. PubMed ID: 21955038
[TBL] [Abstract][Full Text] [Related]
7. Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity.
Bardwell AJ; Abdollahi M; Bardwell L
Biochem J; 2003 Mar; 370(Pt 3):1077-85. PubMed ID: 12529172
[TBL] [Abstract][Full Text] [Related]
8. A MAP kinase docking site is required for phosphorylation and activation of p90(rsk)/MAPKAP kinase-1.
Gavin AC; Nebreda AR
Curr Biol; 1999 Mar; 9(5):281-4. PubMed ID: 10074458
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic Analysis of an Extracellular Signal-Regulated Kinase 2-Interacting Compound that Inhibits Mutant BRAF-Expressing Melanoma Cells by Inducing Oxidative Stress.
Martinez R; Huang W; Samadani R; Mackowiak B; Centola G; Chen L; Conlon IL; Hom K; Kane MA; Fletcher S; Shapiro P
J Pharmacol Exp Ther; 2021 Jan; 376(1):84-97. PubMed ID: 33109619
[TBL] [Abstract][Full Text] [Related]
10. A non-catalytic herpesviral protein reconfigures ERK-RSK signaling by targeting kinase docking systems in the host.
Alexa A; Sok P; Gross F; Albert K; Kobori E; Póti ÁL; Gógl G; Bento I; Kuang E; Taylor SS; Zhu F; Ciliberto A; Reményi A
Nat Commun; 2022 Jan; 13(1):472. PubMed ID: 35078976
[TBL] [Abstract][Full Text] [Related]
11. A bipartite mechanism for ERK2 recognition by its cognate regulators and substrates.
Zhang J; Zhou B; Zheng CF; Zhang ZY
J Biol Chem; 2003 Aug; 278(32):29901-12. PubMed ID: 12754209
[TBL] [Abstract][Full Text] [Related]
12. Structural and Dynamic Features of F-recruitment Site Driven Substrate Phosphorylation by ERK2.
Piserchio A; Ramakrishan V; Wang H; Kaoud TS; Arshava B; Dutta K; Dalby KN; Ghose R
Sci Rep; 2015 Jun; 5():11127. PubMed ID: 26054059
[TBL] [Abstract][Full Text] [Related]
13. Dynamic control of RSK complexes by phosphoswitch-based regulation.
Gógl G; Biri-Kovács B; Póti ÁL; Vadászi H; Szeder B; Bodor A; Schlosser G; Ács A; Turiák L; Buday L; Alexa A; Nyitray L; Reményi A
FEBS J; 2018 Jan; 285(1):46-71. PubMed ID: 29083550
[TBL] [Abstract][Full Text] [Related]
14. Characterization of an ERK-binding domain in microphthalmia-associated transcription factor and differential inhibition of ERK2-mediated substrate phosphorylation.
Molina DM; Grewal S; Bardwell L
J Biol Chem; 2005 Dec; 280(51):42051-60. PubMed ID: 16246839
[TBL] [Abstract][Full Text] [Related]
15. The anti-apoptotic protein PEA-15 is a tight binding inhibitor of ERK1 and ERK2, which blocks docking interactions at the D-recruitment site.
Callaway K; Abramczyk O; Martin L; Dalby KN
Biochemistry; 2007 Aug; 46(32):9187-98. PubMed ID: 17658892
[TBL] [Abstract][Full Text] [Related]
16. Docking sites on substrate proteins direct extracellular signal-regulated kinase to phosphorylate specific residues.
Fantz DA; Jacobs D; Glossip D; Kornfeld K
J Biol Chem; 2001 Jul; 276(29):27256-65. PubMed ID: 11371562
[TBL] [Abstract][Full Text] [Related]
17. The Amino-terminal Domain of the Androgen Receptor Co-opts Extracellular Signal-regulated Kinase (ERK) Docking Sites in ELK1 Protein to Induce Sustained Gene Activation That Supports Prostate Cancer Cell Growth.
Rosati R; Patki M; Chari V; Dakshnamurthy S; McFall T; Saxton J; Kidder BL; Shaw PE; Ratnam M
J Biol Chem; 2016 Dec; 291(50):25983-25998. PubMed ID: 27793987
[TBL] [Abstract][Full Text] [Related]
18. Formation of ternary complex of human biliverdin reductase-protein kinase Cδ-ERK2 protein is essential for ERK2-mediated activation of Elk1 protein, nuclear factor-κB, and inducible nitric-oxidase synthase (iNOS).
Gibbs PE; Miralem T; Lerner-Marmarosh N; Tudor C; Maines MD
J Biol Chem; 2012 Jan; 287(2):1066-79. PubMed ID: 22065579
[TBL] [Abstract][Full Text] [Related]
19. Local destabilization, rigid body, and fuzzy docking facilitate the phosphorylation of the transcription factor Ets-1 by the mitogen-activated protein kinase ERK2.
Piserchio A; Warthaka M; Kaoud TS; Callaway K; Dalby KN; Ghose R
Proc Natl Acad Sci U S A; 2017 Aug; 114(31):E6287-E6296. PubMed ID: 28716922
[TBL] [Abstract][Full Text] [Related]
20. A model of a MAPK•substrate complex in an active conformation: a computational and experimental approach.
Lee S; Warthaka M; Yan C; Kaoud TS; Piserchio A; Ghose R; Ren P; Dalby KN
PLoS One; 2011 Apr; 6(4):e18594. PubMed ID: 21494553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
